Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Azafaros
Biotech
Azafaros' €132M series B will fund brain-penetrant drug trials
Azafaros has secured 132 million euros in series B funds that the Dutch biotech will use to push its brain disease drug through two late-stage trials.
James Waldron
May 13, 2025 7:10am
Former Seagen CEO takes on new role—Chutes & Ladders
Mar 24, 2023 9:30am
Novavax CEO to retire after 12 years—Chutes & Ladders
Jan 13, 2023 9:30am
European rare disease biotech Azafaros grabs $28M
Feb 6, 2020 9:03am
